Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial (Q33470696)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial (English)

1 reference

Europe PubMed Central

27 July 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

author name string

Susanne J J Claessen

1

1 reference

Europe PubMed Central

27 July 2017

Johanna M W Hazes

2

1 reference

Europe PubMed Central

27 July 2017

Margriet A M Huisman

3

1 reference

Europe PubMed Central

27 July 2017

Derkjen van Zeben

4

1 reference

Europe PubMed Central

27 July 2017

Jolanda J Luime

5

1 reference

Europe PubMed Central

27 July 2017

Angelique E A M Weel

6

1 reference

Europe PubMed Central

27 July 2017

publication date

18 June 2009

1 reference

Europe PubMed Central

27 July 2017

BMC Musculoskeletal Disorders

1 reference

Europe PubMed Central

27 July 2017

10

1 reference

Europe PubMed Central

27 July 2017

71

1 reference

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2474-10-71

0 references

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Switching anti-TNF-alpha agents: what is the evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

How to read radiographs according to the Sharp/van der Heijde method.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

21 June 2018

Work and sick leave among patients with early inflammatory joint conditions

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

A prediction rule for disease outcome in patients with Recent-onset undifferentiated arthritis: How to guide individual treatment decisions

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-10-71

21 January 2018

Predictors of sick leave and reduced productivity at work among persons with early inflammatory joint conditions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

31 October 2018

Clear associations between demographic and psychosocial factors and health-related quality of life in patients with early inflammatory joint complaints.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

31 October 2018

Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702315

31 October 2018

Measurement of disability in Dutch rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of rheumatoid arthritis on life activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19538718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2474-10-71

1 reference

Europe PubMed Central

27 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-10-71

9 September 2019

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33470696&oldid=1643783679"